Shenzhen Neptunus Bioengineering Co

Shenzhen Neptunus Bioengineering Co Goodwill/Assets

The Goodwill to Total Assets Ratio of Shenzhen Neptunus Bioengineering Co (000078.SZ) as of Oct 18, 2026 is 0.92 %. In the previous year, Goodwill to Total Assets Ratio was 1.32 % — a change of -30.29% (lower).

Goodwill/Assets

0.92 %

YoY

-30.29%

Last updated:

Goodwill to Total Assets Ratio of Shenzhen Neptunus Bioengineering Co is 2025 0.92 % . Goodwill to Total Assets Ratio of Shenzhen Neptunus Bioengineering Co was 2024 1.32 % . It decreases by -30.29% lower compared to the previous year.

The Shenzhen Neptunus Bioengineering Co Goodwill/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill/Assets
Date
Goodwill/Assets
Jan 1, 2018
9.53 CNY
Jan 1, 2019
8.09 CNY
Jan 1, 2020
6.23 CNY
Jan 1, 2021
6.19 CNY
Jan 1, 2022
4.81 CNY
Jan 1, 2023
2.67 CNY
Jan 1, 2024
1.32 CNY
Jan 1, 2025
0.92 CNY
The Shenzhen Neptunus Bioengineering Co Goodwill/Assets history
YEARGoodwill/AssetsYoY
0.92 %-30.29%
1.32 %-50.79%
2.67 %-44.50%
4.81 %-22.24%
6.19 %-0.52%
6.23 %-23.07%
8.09 %-15.06%
9.53 %-17.16%
11.50 %+301.89%
2.86 %+255.79%
0.80 %+96.01%
0.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shenzhen Neptunus Bioengineering Co Stock analysis

What does Shenzhen Neptunus Bioengineering Co do? Shenzhen Neptunus Bioengineering Co Ltd is a company based in Shenzhen, China, operating within the Health Care sector. The company has been publicly traded since its IPO on December 18, 1998, with a ticker symbol of 000078.SZ and ISIN CNE000000X95. It employs 9,874 people. The company's primary business involves the pharmaceutical industry, focusing on the development and distribution of various medical products. Its main product categories include anti-tumor medications, cardiovascular drugs, marine-derived pharmaceuticals, respiratory treatments, anti-infective products, and additional pharmaceuticals. The company also offers healthcare products, health food, and medical instruments. Shenzhen Neptunus Bioengineering Co Ltd primarily serves the domestic Chinese market, with a significant focus on the East China region. The company's official website is https://www.neptunusbio.com/. No additional details regarding founding year, specific acquisitions, or financial figures beyond the provided data are included in this profile. Shenzhen Neptunus Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shenzhen Neptunus Bioengineering Co stock

Goodwill to Total Assets Ratio of Shenzhen Neptunus Bioengineering Co is 0.92 % in 2025.

Goodwill to Total Assets Ratio of Shenzhen Neptunus Bioengineering Co changed from 1.32 % to 0.92 %, representing a -30.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Shenzhen Neptunus Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Shenzhen Neptunus Bioengineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Shenzhen Neptunus Bioengineering Co

All Key Metrics — Shenzhen Neptunus Bioengineering Co